Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fengling Wang

Showing results (91-100 of 120) with videos related to

Pageof 12
Sort By:
Materials Today. Bio|June 8, 2026
Co-delivery of endoplasmic reticulum-targeted photosensitizer and Ido-1 inhibitor potentiates immunotherapeutic efficacy in triple-negative breast cancerJia Wang, Fengling Wang, Qiang Zhou, et al.
Journal of Cellular and Molecular Medicine|June 21, 2017
Expression of PTEN-long mediated by CRISPR/Cas9 can repress U87 cell proliferationNa Fang, Tingxuan Gu, Yahui Wang, et al.
Frontiers in Endocrinology|July 8, 2021
Identification of Clinical Relevant Molecular Subtypes of PheochromocytomaUmair Ali Khan Saddozai, Fengling Wang, Muhammad Usman Akbar, et al.
Genes|September 9, 2020
OSucs: An Online Prognostic Biomarker Analysis Tool for Uterine CarcinosarcomaYang An, Qiang Wang, Fengjie Sun, et al.
Neoplasia (New York, N.Y.)|February 2, 2021
Discovery of a new inhibitor targeting PD-L1 for cancer immunotherapyFengling Wang, Wenling Ye, Shuang Wang, et al.
Oncology Letters|August 20, 2019
Interactive online consensus survival tool for esophageal squamous cell carcinoma prognosis analysisQiang Wang, Fengling Wang, Jiajia Lv, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|February 13, 2026
Membrane-proximal binding of PSMA facilitates synapse formation with CAR and enhances antitumor activity of PSMA CAR-T cells against prostate cancerJing Li, Dan Li, Yong Huang, et al.
International Journal of Nanomedicine|November 22, 2021
Effective Triple-Negative Breast Cancer Targeted Treatment Using iRGD-Modified RBC Membrane-Camouflaged NanoparticlesJingbin Huang, Wenjing Lai, Qing Wang, et al.
International Journal of Molecular Sciences|February 25, 2023
Identification of CBPA as a New Inhibitor of PD-1/PD-L1 InteractionFengling Wang, Wenling Ye, Yongxing He, et al.
Neoplasia (New York, N.Y.)|May 4, 2019
Gene Expression Profiling Reveals Distinct Molecular Subtypes of Esophageal Squamous Cell Carcinoma in Asian PopulationsFengling Wang, Zhongyi Yan, Jiajia Lv, et al.
Pageof 12

Showing results (91-100 of 120) with videos related to

Sort By:
Pageof 12
Materials Today. Bio|June 8, 2026
Co-delivery of endoplasmic reticulum-targeted photosensitizer and Ido-1 inhibitor potentiates immunotherapeutic efficacy in triple-negative breast cancerJia Wang, Fengling Wang, Qiang Zhou, et al.
Journal of Cellular and Molecular Medicine|June 21, 2017
Expression of PTEN-long mediated by CRISPR/Cas9 can repress U87 cell proliferationNa Fang, Tingxuan Gu, Yahui Wang, et al.
Frontiers in Endocrinology|July 8, 2021
Identification of Clinical Relevant Molecular Subtypes of PheochromocytomaUmair Ali Khan Saddozai, Fengling Wang, Muhammad Usman Akbar, et al.
Genes|September 9, 2020
OSucs: An Online Prognostic Biomarker Analysis Tool for Uterine CarcinosarcomaYang An, Qiang Wang, Fengjie Sun, et al.
Neoplasia (New York, N.Y.)|February 2, 2021
Discovery of a new inhibitor targeting PD-L1 for cancer immunotherapyFengling Wang, Wenling Ye, Shuang Wang, et al.
Oncology Letters|August 20, 2019
Interactive online consensus survival tool for esophageal squamous cell carcinoma prognosis analysisQiang Wang, Fengling Wang, Jiajia Lv, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|February 13, 2026
Membrane-proximal binding of PSMA facilitates synapse formation with CAR and enhances antitumor activity of PSMA CAR-T cells against prostate cancerJing Li, Dan Li, Yong Huang, et al.
International Journal of Nanomedicine|November 22, 2021
Effective Triple-Negative Breast Cancer Targeted Treatment Using iRGD-Modified RBC Membrane-Camouflaged NanoparticlesJingbin Huang, Wenjing Lai, Qing Wang, et al.
International Journal of Molecular Sciences|February 25, 2023
Identification of CBPA as a New Inhibitor of PD-1/PD-L1 InteractionFengling Wang, Wenling Ye, Yongxing He, et al.
Neoplasia (New York, N.Y.)|May 4, 2019
Gene Expression Profiling Reveals Distinct Molecular Subtypes of Esophageal Squamous Cell Carcinoma in Asian PopulationsFengling Wang, Zhongyi Yan, Jiajia Lv, et al.
Pageof 12